PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung CancersAlexander Drilon, Kristoffer Staal Rohrberg, K. Park et al.|Journal of Thoracic Oncology|2019Cited by 81
Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathwaySeulki Lee, Yoon Jun Kim|Clinical and Molecular Hepatology|2020Cited by 57
Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016Atsushi Tanaka, Hajime Takikawa, Xiong Ma et al.|Hepatology International|2016Cited by 55
Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERKSeulki Lee, Yoon Jun Kim|International Journal of Molecular Medicine|2018Cited by 33
Transforming growth factor‑β decreases side population cells in hepatocellular carcinoma in�vitroJong Seung Kim, Yoon Jun Kim|Oncology Letters|2018Cited by 9